- Home
- VNRX vs XTNT Comparison
VNRX vs XTNT Comparison
Compare VNRX & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNRX
- XTNT
- Stock Information
- Founded
- VNRX N/A
- XTNT N/A
- Country
- VNRX United States
- XTNT United States
- Employees
- VNRX N/A
- XTNT N/A
- Industry
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VNRX Health Care
- XTNT Health Care
- Exchange
- VNRX Nasdaq
- XTNT Nasdaq
- Market Cap
- VNRX 58.6M
- XTNT 60.9M
- IPO Year
- VNRX N/A
- XTNT N/A
- Fundamental
- Price
- VNRX $0.55
- XTNT $0.49
- Analyst Decision
- VNRX Strong Buy
- XTNT Strong Buy
- Analyst Count
- VNRX 4
- XTNT 1
- Target Price
- VNRX $4.17
- XTNT $3.00
- AVG Volume (30 Days)
- VNRX 129.2K
- XTNT 40.5K
- Earning Date
- VNRX 05-12-2025
- XTNT 03-06-2025
- Dividend Yield
- VNRX N/A
- XTNT N/A
- EPS Growth
- VNRX N/A
- XTNT N/A
- EPS
- VNRX N/A
- XTNT N/A
- Revenue
- VNRX $1,285,827.00
- XTNT $117,267,000.00
- Revenue This Year
- VNRX $71,446.31
- XTNT $15.56
- Revenue Next Year
- VNRX N/A
- XTNT $22.39
- P/E Ratio
- VNRX N/A
- XTNT N/A
- Revenue Growth
- VNRX 97.50
- XTNT 28.44
- 52 Week Low
- VNRX $0.43
- XTNT $0.33
- 52 Week High
- VNRX $1.02
- XTNT $1.24
- Technical
- Relative Strength Index (RSI)
- VNRX 46.10
- XTNT 48.33
- Support Level
- VNRX $0.51
- XTNT $0.45
- Resistance Level
- VNRX $0.57
- XTNT $0.51
- Average True Range (ATR)
- VNRX 0.04
- XTNT 0.05
- MACD
- VNRX -0.00
- XTNT 0.00
- Stochastic Oscillator
- VNRX 40.00
- XTNT 54.00
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.